Lv4
510 积分 2021-07-31 加入
Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity — A Phase 2 Trial
1天前
已完结
Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b/2a randomised controlled study
1天前
已完结
Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial
1天前
已完结
2024 Clinical Practice Guidelines for the Diagnosis and Pharmacologic Treatment of Overweight and Obesity by the Korean Society for the Study of Obesity
2天前
已完结
Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials
3天前
已完结
Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials
3天前
已关闭
肥胖患者的长期体重管理及药物临床应用指南(2024版)
3天前
已完结
Cebranopadol for the Treatment of Chronic Pain
15天前
已完结
肾性贫血新型治疗药物一莫立司他
20天前
已完结
CERA: third-generation erythropoiesis-stimulating agent
21天前
已完结
皖公网安备34019202002308
